SKB571

· Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for SKB571, covering 2025-12-29 to 2026-02-06. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Study of SKB571 in Patients With Lung Cancer [Phase 2]